Volcano CEO says FFR market may grow to $2B The company CEO said that both Volcano (VOLC) and St.Jude (STJ) are expanding in a “duopoly market in fractional flow reserve or FFR technology. The fractional flow reserve procedure is useful in testing for the need to perform angioplasty or stenting. This information is from a recorded webcast of presentation at The 31st Annual J.P. Morgan Healthcare Conference. Originally presented January 8th, 2013, 11:00 AM Pacific Time
News For VOLC;STJ From The Last 14 Days
Check below for free stories on VOLC;STJ the last two weeks.